Hookipa Biotech Gmbh
Clinical trials sponsored by Hookipa Biotech Gmbh, explained in plain language.
-
Experimental vaccines show promise against HPV-Driven cancers
Disease control CompletedThis completed phase I/II trial tested two experimental vaccines, HB-201 and HB-202, in 198 people with HPV 16+ cancers. The goal was to find a safe dose and see if the vaccines could shrink tumors. Participants received the vaccines alone or with standard treatments like pembrol…
Phase: PHASE1, PHASE2 • Sponsor: Hookipa Biotech GmbH • Aim: Disease control
Last updated Jun 26, 2026 17:14 UTC
-
Real-world data on keytruda and opdivo for HPV throat cancer could shape future trials
Knowledge-focused CompletedThis study looked at 662 patients with HPV-positive throat cancer that had spread or come back. Researchers wanted to see how patients were treated with pembrolizumab (Keytruda) or nivolumab (Opdivo), with or without chemotherapy, in real-world settings. The goal was to gather in…
Sponsor: Hookipa Biotech GmbH • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:18 UTC